Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title	Author(s)
	2016	Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia	Larance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.
	2015	Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague-Dawley and Dark Agouti rats	Licari, G.; Somogyi, A.A.; Milne, R.W.; Sallustio, B.C.
	2015	Pharmacogenetics of opioid response	Somogyi, A.A.; Coller, J.K.; Barratt, D.T.
	2015	Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids	Peacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L.
	2015	Wetlands and human health	Finlayson, C.M.; Horwitz, P.; Weinstein, P.; Finlayson, C.M.; Horwitz, P.; Weinstein, P.
	2015	A comparison of patterns of spontaneous adverse drug reaction reporting with St. John's Wort and fluoxetine during the period 2000-2013	Hoban, C.L.; Byard, R.W.; Musgrave, I.F.
	2015	Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer	Saladores, P.; Muerdter, T.; Eccles, D.; Chowbay, B.; Zgheib, N.K.; Winter, S.; Ganchev, B.; Eccles, B.; Gerty, S.; Tfayli, A.; Lim, J.S.L.; Yap, Y.S.; Ng, R.C.H.; Wong, N.S.; Dent, R.; Habbal, M.Z.; Schaeffeler, E.; Eichelbaum, M.; Schroth, W.; Schwab, M.; et al.
	2015	Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation	Peacock, A.; Degenhardt, L.; Hordern, A.; Larance, B.; Cama, E.; White, N.; Kihas, I.; Bruno, R.
	2015	The characteristics of a cohort who tamper with prescribed and diverted opioid medications	Larance, B.; Lintzeris, N.; Bruno, R.; Peacock, A.; Cama, E.; Ali, R.; Kihas, I.; Hordern, A.; White, N.; Degenhardt, L.
	2015	Early social environment affects the endogenous oxytocin system: a review and future directions	Alves, E.; Fielder, A.; Ghabriel, N.; Sawyer, M.; Buisman-Pijlman, F.T.A.
	2015	Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomes	Martin, J.H.; Phillips, E.; Thomas, D.; Somogyi, A.A.
	2015	A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone	Peacock, A.; Degenhardt, L.; Larance, B.; Cama, E.; Lintzeris, N.; Ali, R.; Bruno, R.
	2014	Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies	Md Dom, Z.; Noll, B.; Coller, J.; Somogyi, A.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
	2014	Controlled release and bioactivity of the monoclonal antibody rituximab from a porous matrix: a potential in situ therapeutic device	Simovic, S.; Diener, K.; Bachhuka, A.; Kant, K.; Losic, D.; Hayball, J.; Brown, M.; Vasilev, K.
	2014	Lethal hepatocellular necrosis associated with herbal polypharmacy in a patient with chronic hepatitis B infection	Gilbert, J.; Musgrave, I.; Hoban, C.; Byard, R.
	2014	Oxytocin treatment in pediatric populations	Taylor, A.E.; Lee, H.E.; Buisman-Pijlman, F.T.A.
	2014	Understanding the pharmacology of headache	Rolan, P.
	2014	Why social attachment and oxytocin protect against addiction and stress: insights from the dynamics between ventral and dorsal corticostriatal systems	Tops, M.; Koole, S.L.; Ijzerman, H.; Buisman-Pijlman, F.T.A.
	2014	Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake	Drury, N.E.; Licari, G.; Chong, C.R.; Howell, N.J.; Frenneaux, M.P.; Horowitz, J.D.; Pagano, D.; Sallustio, B.C.
	2014	The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians	Kerr, K.P.; Mate, K.E.; Magin, P.J.; Marley, J.; Stocks, N.P.; Disler, P.; Pond, C.D.